Galenicap

Galenicap is a dynamic pharmaceutical company dedicated to enhancing existing medicines to provide patients with better and safer treatment options. With a focus on innovation, Galenicap is committed to the early-stage development of value-added medicines, improving upon established treatments to meet the evolving needs of healthcare. The company operates out of its primary location in Brussels, BE.

Working in close collaboration with clinical experts and physicians from leading university hospitals and medical schools, Galenicap drives projects from initial concept to proof-of-concept. This collaborative approach ensures that each project benefits from the latest clinical insights and advancements, resulting in formulations with strong intellectual property and robust clinical data in patients. Galenicap is dedicated to pioneering advancements in pharmaceutical treatments.

Galenicap strives to improve patient outcomes through rigorous research and development. The company's commitment to excellence and innovation positions it as a key player in the pharmaceutical industry. We invite the manager of Galenicap to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions and capabilities.